Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
It is clear that our CEO cares hugely about making this work and equally about rewarding loyal shareholders.
This share has been oversold for what ever reason. The market will bounce and recognise the value here is significant. As our brokers say £4.20 or £9.50 are realistic. However this has potential to be worth billions as a multi viral treatment. It is the end game that counts.
I take it all the genuine investors in this share are continuing to post links to the Home Trials on their social media. Please encourage your friends and family to all share the link.
https://www.covidtrialathome.com/
Anyone not sure about why our drug is so special please understand we have Patent Protection to deliver a heavy dose of Interferon Beta direct to the lungs. IV or Injection has side effects and can only deliver limited quantities.
What we are demonstrating through a growing data bank, is how our drug works, our drug is safe and our drug has the potential to be a multi platform anti viral treatment for use At Home and in Hospitals.
Also note the new nebuliser can be adapted to fit a ventilator. This additional trial will be challenging to set up, however could prove life saving.
I’m proud to be a shareholder here. I’m so so proud of Richard and the team at Synairgen. I am disappointed at the level of support from UKGOV to help raise awareness of the Home Trials.
We now know we will have the following:
Phase 3 Hospital trials across 20 countries.
Phase 2 Home trial in America
Phase 2 Home trials in Uk.
There are other collaborations taking place as well.
News on the Phase 3 trials will land any day. This might be staggered as we will see different authorities approving at different times. FDA is very keen to get started.
No this is not a one trick pony.
This is a anti viral multi platform drug in the making.
Highly undervalued at this level.
A little research would demonstrate the size of the prize here.
The team in Southampton are working 14 hour days to deliver the multiple trials across 20 countries.
You heard just today that a Home Trial is being set up in America. This is major news.
Synairgen confirmed that they would only communicate chunky news. They are not issuing RNS’s for every small win. It distracts the team from the bigger goal.
Synairgen would have to RNS any set back. So no news is good news.
These trials would normally take 6 months to set up. Synairgen will have done it in 1 month. The FDA is a hungry beast, however once we get started the UK trials won’t matter !
This company is shaping itself into a major Pharmaceutical with a multi platform drug which can treat multiple virus.
This company is a gem and very very unique.
The Government supported the Plasma trials. The Government supported the vaccine trials.
What a stupid thing to say.
Matt Han**** has actively supported the recovery trials. He has actively named the vaccine phase 3 trials.
Expanding the Home trials into America makes perfect sense. Especially with the UKGOV has failed so badly to support this Phase2 trial.
Marik very sensible post. FINCAP reconfirmed their £4.20 yesterday and NUMs continues with their £9+
When you see the price derisked drugs sell for you will see that both the brokers and Marik are in the ball park.
SNG001 as a multi platform anti viral drug has a significant role to play in medicine going forward.
We just need to hold our nerve and ignore the virus on this board.
Anyone watching L2 will see the total control the Automatic trades have over our share price. I believe Leonard Licht is selling his shares. He had 5m on the 13th and has been invested since the 6p days.
It is funny reading the trolling going on here. A Phase 3 trial across 20 countries would normally take a company 6 months to set up. It looks like Synairgen is will do it in under a month from funding. The complexity of meeting every regulatory body approvals is immense.
When the start of Phase 3 is RNS’d the hard work continues. We have the Home Trials gathering pace, Phase 3 and all other studies.
The share price is oversold IMO. A huge over reaction to the Vaccines. SNG001 is going to be a SuperDrug worth billions!
I am personally buying at this level and holding for 2021 mega news.
Exciting times for true investors. As for the virus on this board, don’t worry SNG001 will wipe them out on the next RNS !
Hi mate
LL has been in for a Long time and even at 90p he’s seeing a very nice return.
We will never know why he is selling, same could have been said about Acacia and we all know what happened next !
See Mark Brewer reconfirmed 420p target today.
It only hurts when you sell. If you believe in your research into Synairgen and the management you either hold or buy.
Personally I see some news landing as soon as LL has finished selling, which will be any day now.
GLA
It such a shame LSE doesn’t regulate these pages.
All the good debate (positive and negative) is simply lost in the mass of trolling.
Having said that always a good sign when the trolls turn up ;-)
Anyone want to see MM’s manipulate the price look at L2 !
52k and 50k sitting there holding the price down.
SNG001 protects against virus that infects the body and LSE board !
Last time I wrote that the share price was 32p and trolls were saying it would drop further and our drug would fail.
How wrong they were !
Vaccines for C19 are a good thing. A new Anti Virus drug to treat numerous infections is equally exciting.
Catch up again soon !
Morning
This remind me of when the share went from 70p to 32p.
I loaded up then and I’m loading up now.
I think we are being played. The AIM market is the easiest in the world to manipulate and frankly the rules are never enforced. The lack of TR1’s the lack or transparency is all part of the manipulation. The A trades take the price to where the MM’s want it.
Anyhow back to Synairgen. It is clear we will get news that Phase 3 has started within the next 10 days. It is clear that discussions are ongoing with Government agencies around the world. It is also clear that Richard and the team in Southampton have a plan to build maximum value prior to even considering a Partnership/ License Deal. It is also clear that SNG001 is much bigger than Covid19.
Short term frustrations in share price will so swap into excitement.
I am holding for the end game !!!
I am still heavily invested and have made the most of the sub £1 buy price.
The goal for Synairgen at the moment is data collection. This will come from Home Trial, Phase3 trial and other places. I expect Phase 3 trials to start end November (trials normally take 6 months to set up, so this is super quick).
Anyone panicking about vaccines should relax. RM and the II’s all knew vaccines were in the pipeline. The role of SNG001 will be significant for Covid19, COPD and 100’s of other uses going forward (yes 100’s). As a result we will see Synairgen partner or merge or even get taken over by a Big Pharma. This will be necessary to build SNG001 into a SuperDrug.
For me and in the words of RM. This is all about the End Game, short term only impact traders. Synairgen is a Covid19 stock, but it is also allot allot more.
The end game is my focus and whilst the match is being played, I am taking full advantage of the cheap shares.
GLA and enjoy the TR1’s and updates due later this month. I’ll tune out again until news lands.
Yes I will take my full quota.
This will be 1 in 37 I believe.
As mentioned already SNG001 is multi use. It will be a significant drug going forward. The fact Richard has managed to raise £87m and maintain 100% holding for us shareholders is fantastic news and will maximise our return.
Let’s be clear this is a global drug trial now.
FDA are backing the trial !!
Phase 3 trials can be stopped if progressing well or poorly.
So if America see significant positive results they can approve for extended use mid trial.
People need to understand this is now a global drug and now a truly global company.
If this drops tomorrow it will be heavily bought into.
I have heard the £80m placing is already oversubscribed!
We should see new highs this week.
This is AIM so expect some games. £9.90 target is now very much in play.
SNG001 is now a global priority drug in the treatment of Covid19.
Synairgen is now funded into production whilst maintaining 100% ownership.
Anyone trying to troll against this news are desperate.
Brilliant news and well done Richard !